Registro:

Referencias:

• De Vos, N., Van Hoovels, L., Vankeerberghen, A., Monitoring of herpes simplex virus in the lower respiratory tract of critically ill patients using real-time PCR: A prospective study (2009) Clin Microbiol Infect, 15, pp. 358-363
• Gooskens, J., Templeton, K.E., Claas, E.C., Van Bussel, M.J., Smit, V.T., Kroes, A.C., Quantitative detection of herpes simplex virus DNA in the lower respiratory tract (2007) Journal of Medical Virology, 79 (5), pp. 597-604. , DOI 10.1002/jmv.20861
• Mosca, J.D., Bednarik, D.P., Raj, N.B.K., Herpes simplex virus type-1 can reactivate transcription of latent human immunodeficiency virus (1987) Nature, 325 (6099), pp. 67-70. , DOI 10.1038/325067a0
• Koelle, D.M., Wald, A., Herpes simplex virus: The importance of asymptomatic shedding (2000) Journal of Antimicrobial Chemotherapy, 45 (TOPIC T3), pp. 1-8
• Corey, L., Wald, A., Celum, C.L., The effects of herpes simplex virus-2 on HIV-1 acquisition and transmission: A review of two overlapping epidemics (2004) J Acquir Immune Defic Syndr, 35, pp. 435-450
• Turville, S.G., Stuart, G., Aravantinou, M., Efficacy of Carraguard-based microbicides in vivo despite variable in vitro activity (2008) PLoS One, 3, pp. e3162
• Skoler-Karpoff, S., Ramjee, G., Ahmed, K., Efficacy of Carraguard for prevention of HIV infection in women in South Africa: A randomised, double-blind, placebo-controlled trial (2008) Lancet, 372, pp. 1977-1987
• Maguire, R.A., Microbicide product development (2008) Curr Opin HIV AIDS, 3, pp. 554-557
• Fernandez-Romero, J.A., Thorn, M., Turville, S.G., Titchen, K., Sudol, K., Li, J., Miller, T., Phillips, D.M., Carrageenan/MIV-150 (PC-815), a combination microbicide (2007) Sexually Transmitted Diseases, 34 (1), pp. 9-14. , DOI 10.1097/01.olq.0000223287.46097.4b, PII 0000743520070100000002
• Carlucci, M.J., Scolaro, L.A., Damonte, E.B., Inhibitory action of natural carrageenans on herpes simplex virus infection of mouse astrocytes (1999) Chemotherapy, 45 (6), pp. 429-436. , DOI 10.1159/000007236
• Carlucci, M.J., Ciancia, M., Matulewicz, M.C., Cerezo, A.S., Damonte, E.B., Antiherpetic activity and mode of action of natural carrageenans of diverse structural types (1999) Antiviral Research, 43 (2), pp. 93-102. , DOI 10.1016/S0166-3542(99)00038-8, PII S0166354299000388
• Liu, J., Thorp, S.C., Cell surface heparan sulfate and its roles in assisting viral infections (2002) Medicinal Research Reviews, 22 (1), pp. 1-25. , DOI 10.1002/med.1026
• Carlucci, M.J., Scolaro, L.A., Damonte, E.B., Herpes simplex virus type 1 variants arising after selection with an antiviral carrageenan: Lack of correlation between drug susceptibility and syn phenotype (2002) Journal of Medical Virology, 68 (1), pp. 92-98. , DOI 10.1002/jmv.10174
• Goodman, J.L., Engel, J.P., Altered pathogenesis in herpes simplex virus type 1 infection due to a syncytial mutation mapping to the carboxy terminus of glycoprotein (1991) Br J Virol, 65, pp. 1770-1778
• Pertel, P.E., Spear, P.G., Modified entry and syncytium formation by herpes simplex virus type 1 mutants selected for resistance to heparin inhibition (1996) Virology, 226 (1), pp. 22-33. , DOI 10.1006/viro.1996.0624
• Muggeridge, M.I., Grantham, M.L., Johnson, F.B., Identification of syncytial mutations in a clinical isolate of herpes simplex virus 2 (2004) Virology, 328 (2), pp. 244-253. , DOI 10.1016/j.virol.2004.07.027, PII S0042682204004970
• Haffey, M.L., Spear, P.G., Alterations in glycoprotein gB specified by mutants and their partial revertants in herpes simplex virus type 1 and relationship to other mutant phenotypes (1980) Journal of Virology, 35 (1), pp. 114-128
• Carlucci, M.J., Pujol, C.A., Ciancia, M., Noseda, M.D., Matulewicz, M.C., Damonte, E.B., Cerezo, A.S., Antiherpetic and anticoagulant properties of carrageenans from the red seaweed Gigartina skottsbergii and their cyclized derivatives: Correlation between structure and biological activity (1997) International Journal of Biological Macromolecules, 20 (2), pp. 97-105. , DOI 10.1016/S0141-8130(96)01145-2, PII S0141813096011452
• Andrei, G., Balzarini, J., Fiten, P., De Clercq, E., Opdenakker, G., Snoeck, R., Characterization of herpes simplex virus type 1 thymidine kinase mutants selected under a single round of high-dose brivudin (2005) Journal of Virology, 79 (9), pp. 5863-5869. , DOI 10.1128/JVI.79.9.5863-5869.2005
• Frobert, E., Ooka, T., Cortay, J.C., Lina, B., Thouvenot, D., Morfin, F., Herpes simplex virus thymidine kinase mutations associated with resistance to acyclovir: A site-directed mutagenesis study (2005) Antimicrobial Agents and Chemotherapy, 49 (3), pp. 1055-1059. , DOI 10.1128/AAC.49.3.1055-1059.2005
• Chibo, D., Druce, J., Sasadeusz, J., Birch, C., Molecular analysis of clinical isolates of acyclovir resistant herpes simplex virus (2004) Antiviral Research, 61 (2), pp. 83-91. , DOI 10.1016/j.antiviral.2003.08.018
• Morfin, F., Thouvenot, D., Herpes simplex virus resistance to antiviral drugs (2003) Journal of Clinical Virology, 26 (1), pp. 29-37. , DOI 10.1016/S1386-6532(02)00263-9, PII S1386653202002639
• Wudunn, D., Spear, P.G., Initial interaction of herpes simplex virus with cells is binding to heparan sulfate (1989) J Virol, 63, pp. 52-58
• Herold, B.C., Wudunn, D., Soltys, N., Glycoprotein C of herpes simplex virus type 1 plays a principal role in the adsorption of virus to cells and in infectivity (1991) J Virol, 65, pp. 1090-1098
• Trybala, E., Liljeqvist, J.A., Svennerholm, B., Herpes simplex type 1 and 2 differ in their interaction with heparan sulfate (2000) J Virol, 74, pp. 9106-9114
• Diakidi-Kosta, A., Michailidou, G., Kontogounis, G., Sivropoulou, A., Arsenakis, M., A single amino acid substitution in the cytoplasmic tail of the glycoprotein B of herpes simplex virus 1 affects both syncytium formation and binding to intracellular heparan sulfate (2003) Virus Research, 93 (1), pp. 99-108. , DOI 10.1016/S0168-1702(03)00070-4
• Lingen, M., Seck, T., Weise, K., Single amino acid substitutions in the glycoprotein B carboxy terminus influence the fusion from without property of herpes simplex virus type 1 (1995) J Gen Virol, 76, pp. 1843-1849
• Wilson, D.W., Davis-Poynter, N., Minson, A.C., Mutations in the cytoplasmic tail of herpes simplex virus glycoprotein H suppress cell fusion by a syncytial strain (1994) Journal of Virology, 68 (11), pp. 6985-6993
• Tyler, K.L., Fields, B.N., Pathogenesis of viral infections (1991) Fundamental Virology, pp. 191-239. , Fields BN, Knipe DM, eds 2nd ed. New York, NY: Raven Press
• Reading, P.C., Whitney, P.G., Batt, D.P., NK cells contribute to the early clearance of HSV-1 from the lung but cannot control replication in the central nervous system following intranasal infection (2006) Eur J Immunol, 36, pp. 897-905
• Burgos, J.S., Serrano-Saiz, E., Sastre, I., Valdivieso, F., ICP47 mediates viral neuroinvasiveness by induction of TAP protein following intravenous inoculation of herpes simplex virus type 1 in mice (2006) Journal of NeuroVirology, 12 (6), pp. 420-427. , DOI 10.1080/13550280601009546, PII K006855Q38J34T47
• Murphy, E.A., Davis, J.M., Brown, A.S., Effect of IL-6 deficiency on susceptibility to HSV-1 respiratory infection and intrinsic macrophage antiviral resistance (2008) J Interferon Cytokine Res, 28, pp. 589-596
• Sarmiento, M., Intrinsic resistance to viral infection. Mouse macrophage restriction of herpes simplex virus replication (1988) Journal of Immunology, 141 (8), pp. 2740-2748
• Van Iwaarden, J.F., Van Strijp, J.A., Visser, H., Binding of surfactant protein A (SP-A) to herpes simplex virus type 1-infected cells is mediated by the carbohydrate moiety of SP-A (1992) J Biol Chem, 267, pp. 25039-25043
• Ihrcke, N.S., Parker, W., Reissner, K.J., Regulation of platelet heparanase during inflammation: Role of pH and proteinases (1998) J Cell Physiol, 175, pp. 255-260
• Christophers, J., Clayton, J., Craske, J., Ward, R., Collins, P., Trowbridge, M., Darby, G., Survey of resistance of herpes simplex virus to acyclovir in northwest England (1998) Antimicrobial Agents and Chemotherapy, 42 (4), pp. 868-872
• Sande, M.A., Armstrong, D., Corey, L., Lawrence Drew, W., Gilbert, D., Moellering Jr., R.C., Smith, L.G., Perspectives on switching oral acyclovir from prescription to over-the-counter status: Report of a consensus panel (1998) Clinical Infectious Diseases, 26 (3), pp. 659-663
• Kainulainen, V.H., Wang, H., Schick, C., Syndecans, heparan sulfate proteoglycans, maintain the proteolytic balance of acute wound fluids (1998) J Biol Chem, 273, pp. 11563-11568
• Oragui, E., Nadel, S., Kyd, P., Increased excretion of urinary glycosaminoglycans in meningococcal septicemia and their relationship to proteinuria (2000) Crit Care Med, 28, pp. 3002-3008
• Marchant, J., Roe, A., Genital herpes: Recognizing and addressing patients' needs (1997) Herpes, 4 (2), pp. 36-41
• Porteous, C., Bradley, J.A., Hamilton, D.N.H., Herpes simplex virus reactivation in surgical patients (1984) Critical Care Medicine, 12 (8), pp. 626-628
• Luyt, C.-E., Combes, A., Deback, C., Aubriot-Lorton, M.-H., Nieszkowska, A., Trouillet, J.-L., Capron, F., Chastre, J., Herpes simplex virus lung infection in patients undergoing prolonged mechanical ventilation (2007) American Journal of Respiratory and Critical Care Medicine, 175 (9), pp. 935-942. , http://ajrccm.atsjournals.org/cgi/reprint/175/9/935, DOI 10.1164/rccm.200609-1322OC
• Ong, G.M., Lowry, K., Mahajan, S., Wyatt, D.E., Simpson, C., O'Neill, H.J., McCaughey, C., Coyle, P.V., Herpes Simplex Type 1 Shedding Is Associated with Reduced Hospital Survival in Patients Receiving Assisted Ventilation in a Tertiary Referral Intensive Care Unit (2004) Journal of Medical Virology, 72 (1), pp. 121-125. , DOI 10.1002/jmv.10524
• Mertz, G.J., Rosenthal, S.L., Stanberry, L.R., Is herpes simplex virus type 1 (HSV-1) now more common than HSV-2 in first episodes of genital herpes? (2003) Sexually Transmitted Diseases, 30 (10), pp. 801-802. , DOI 10.1097/01.OLQ.0000093080.55201.D1

Citas:

---------- APA ----------

---------- CHICAGO ----------

---------- MLA ----------

---------- VANCOUVER ----------